UBS AM
ORIC icon

UBS AM’s Oric Pharmaceuticals ORIC Stock Holding History

UBS AM’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
54,239
+3,457
+7% +$39.2K ﹤0.01% 2464
2025
Q4 		$415K Buy
50,782
+27,547
+119% +$317K ﹤0.01% 2359
2025
Q3 		$279K Buy
+23,235
New +$244K ﹤0.01% 2208
2025
Q2 		– Sell
-509,179
Closed -$2.84M – 2695
2025
Q1 		$2.84M Buy
509,179
+473,600
+1,331% +$4.14M ﹤0.01% 1834
2024
Q4 		$287K Buy
35,579
+12,545
+54% +$115K ﹤0.01% 2616
2024
Q3 		$236K Sell
23,034
-19,286
-46% -$191K ﹤0.01% 2747
2024
Q2 		$299K Buy
+42,320
New +$379K ﹤0.01% 2722
2022
Q2 		– Sell
-13,033
Closed -$69.6K – 2747
2022
Q1 		$69.6K Hold
13,033
– – ﹤0.01% 2754
2021
Q4 		$192K Hold
13,033
– – ﹤0.01% 2770
2021
Q3 		$273K Hold
13,033
– – ﹤0.01% 2637
2021
Q2 		$231K Buy
13,033
+2,033
+18% +$44.5K ﹤0.01% 2694
2021
Q1 		$270K Buy
11,000
+3,600
+49% +$114K ﹤0.01% 2506
2020
Q4 		$250K Buy
+7,400
New +$212K ﹤0.01% 2453
2020
Q3 		– Sell
-12,775
Closed -$431K – 2503
2020
Q2 		$431K Buy
+12,775
New +$408K ﹤0.01% 2178

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return